Review



mouse trem2 antibody  (Bio-Techne corporation)


Bioz Verified Symbol Bio-Techne corporation is a verified supplier
Bioz Manufacturer Symbol Bio-Techne corporation manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Bio-Techne corporation mouse trem2 antibody
    Mouse Trem2 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 99/100, based on 141 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse trem2 antibody/product/Bio-Techne corporation
    Average 99 stars, based on 141 article reviews
    mouse trem2 antibody - by Bioz Stars, 2026-05
    99/100 stars

    Images



    Similar Products

    99
    Bio-Techne corporation mouse trem2 antibody
    Mouse Trem2 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse trem2 antibody/product/Bio-Techne corporation
    Average 99 stars, based on 1 article reviews
    mouse trem2 antibody - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    93
    R&D Systems anti human mouse trem2
    Anti Human Mouse Trem2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti human mouse trem2/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    anti human mouse trem2 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    95
    R&D Systems trem2
    Trem2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/trem2/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    trem2 - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    95
    R&D Systems rat anti trem2
    Rat Anti Trem2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rat anti trem2/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    rat anti trem2 - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    95
    R&D Systems anti trem2
    Anti Trem2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti trem2/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    anti trem2 - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    96
    R&D Systems myeloid cells 2
    Reduced tyrosine hydroxylase (TH) expression in the hippocampus of htauE14 rats and increased Brain‐Derived Neurotropic Factor (BDNF) expression following early enrichment. (A) Relative optical density (ROD) of TH expression across different groups. N = 4F/4M (cGFP), 6F/4M (cE14), 4F/2M (eSTR.E14), 3F/3M (eER.E14), 5F/3M (lSTR.E14), and 5F/1M (lER.E14). (B) ROD of BDNF expression, showing increased levels with early enrichment. N = 5F/5M (cGFP), 6F/6M (cE14), 6F/2M (eSTR.E14), 4F/4M (eER.E14), 6F/4M (lSTR.E14), and 6F/2M (lER.E14). (C) ROD of glucocorticoid receptor (GR) expression across groups. N = 5F/5M (cGFP), 6F/6M (cE14), 6F/2M (eSTR.E14), 4F/4M (eER.E14), 6F/4M (lSTR.E14), and 6F/2M (lER.E14). (D) ROD of Triggering Receptor Expressed on Myeloid <t>cells</t> <t>2</t> <t>(TREM2)</t> expression across groups. N = 5F/5M (cGFP), 6F/6M (cE14), 6F/2M (eSTR.E14), 4F/3M (eER.E14), 6F/4M (lSTR.E14), and 5F/2M (lER.E14). (E) ROD of tumor necrosis factor α (TNFα) expression across groups. N = 4F/5M (cGFP), 6F/5M (cE14), 5F/2M (eSTR.E14), 3F/4M (eER.E14), 6F/3M (lSTR.E14), and 5F/2M (lER.E14). * p < 0.05; ** p < 0.01.
    Myeloid Cells 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/myeloid cells 2/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    myeloid cells 2 - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    95
    R&D Systems pe anti mouse trem2
    (A, C). Representative immunofluorescence images of the medial corpus callosum in the brain and the dorsal region in the lumbar spinal cord stained with antibodies for MerTK and <t>TREM2.</t> (B, D) Mean intensities graphed to depict the comparison between brain and spinal cord. Mean intensities were obtained using Fiji Image J software. Error bars represent standard error of the mean. Statistical analysis was performed using a 3-way ANOVA with Tukey’s post-hoc analysis, n = 5 – 15 where each sample represents a different animal, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p <0.0001.
    Pe Anti Mouse Trem2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pe anti mouse trem2/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    pe anti mouse trem2 - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    Image Search Results


    Reduced tyrosine hydroxylase (TH) expression in the hippocampus of htauE14 rats and increased Brain‐Derived Neurotropic Factor (BDNF) expression following early enrichment. (A) Relative optical density (ROD) of TH expression across different groups. N = 4F/4M (cGFP), 6F/4M (cE14), 4F/2M (eSTR.E14), 3F/3M (eER.E14), 5F/3M (lSTR.E14), and 5F/1M (lER.E14). (B) ROD of BDNF expression, showing increased levels with early enrichment. N = 5F/5M (cGFP), 6F/6M (cE14), 6F/2M (eSTR.E14), 4F/4M (eER.E14), 6F/4M (lSTR.E14), and 6F/2M (lER.E14). (C) ROD of glucocorticoid receptor (GR) expression across groups. N = 5F/5M (cGFP), 6F/6M (cE14), 6F/2M (eSTR.E14), 4F/4M (eER.E14), 6F/4M (lSTR.E14), and 6F/2M (lER.E14). (D) ROD of Triggering Receptor Expressed on Myeloid cells 2 (TREM2) expression across groups. N = 5F/5M (cGFP), 6F/6M (cE14), 6F/2M (eSTR.E14), 4F/3M (eER.E14), 6F/4M (lSTR.E14), and 5F/2M (lER.E14). (E) ROD of tumor necrosis factor α (TNFα) expression across groups. N = 4F/5M (cGFP), 6F/5M (cE14), 5F/2M (eSTR.E14), 3F/4M (eER.E14), 6F/3M (lSTR.E14), and 5F/2M (lER.E14). * p < 0.05; ** p < 0.01.

    Journal: Alzheimer's & Dementia

    Article Title: Sex and life experience shape locus coeruleus pretangle tau pathology

    doi: 10.1002/alz.71285

    Figure Lengend Snippet: Reduced tyrosine hydroxylase (TH) expression in the hippocampus of htauE14 rats and increased Brain‐Derived Neurotropic Factor (BDNF) expression following early enrichment. (A) Relative optical density (ROD) of TH expression across different groups. N = 4F/4M (cGFP), 6F/4M (cE14), 4F/2M (eSTR.E14), 3F/3M (eER.E14), 5F/3M (lSTR.E14), and 5F/1M (lER.E14). (B) ROD of BDNF expression, showing increased levels with early enrichment. N = 5F/5M (cGFP), 6F/6M (cE14), 6F/2M (eSTR.E14), 4F/4M (eER.E14), 6F/4M (lSTR.E14), and 6F/2M (lER.E14). (C) ROD of glucocorticoid receptor (GR) expression across groups. N = 5F/5M (cGFP), 6F/6M (cE14), 6F/2M (eSTR.E14), 4F/4M (eER.E14), 6F/4M (lSTR.E14), and 6F/2M (lER.E14). (D) ROD of Triggering Receptor Expressed on Myeloid cells 2 (TREM2) expression across groups. N = 5F/5M (cGFP), 6F/6M (cE14), 6F/2M (eSTR.E14), 4F/3M (eER.E14), 6F/4M (lSTR.E14), and 5F/2M (lER.E14). (E) ROD of tumor necrosis factor α (TNFα) expression across groups. N = 4F/5M (cGFP), 6F/5M (cE14), 5F/2M (eSTR.E14), 3F/4M (eER.E14), 6F/3M (lSTR.E14), and 5F/2M (lER.E14). * p < 0.05; ** p < 0.01.

    Article Snippet: Membranes were stained with Ponceau S, blocked, and incubated with primary antibodies against brain‐derived neurotrophic factor (BDNF) (1:2000; Abcam, ab108319), glucocorticoid receptor (GR; 1:2000; Thermo Fisher Scientific, MA1‐510), Triggering Receptor Expressed on Myeloid Cells 2 (TREM2; 1:5000; R&D Systems; AF1729), TH (1:5000; Millipore Sigma, MAB318), tumor necrosis factor α (TNFα; 1:2000; Abcam, ab6671), DBH (1:2000; EMD Millipore, MAB508), s262 ptau (1:2000; Abcam, ab92627), T22 (1:2000; Millipore Sigma, ABN454) and Tau5 (1:3000, Millipore, 577801) followed by HRP‐conjugated secondary antibodies.

    Techniques: Expressing, Derivative Assay

    (A, C). Representative immunofluorescence images of the medial corpus callosum in the brain and the dorsal region in the lumbar spinal cord stained with antibodies for MerTK and TREM2. (B, D) Mean intensities graphed to depict the comparison between brain and spinal cord. Mean intensities were obtained using Fiji Image J software. Error bars represent standard error of the mean. Statistical analysis was performed using a 3-way ANOVA with Tukey’s post-hoc analysis, n = 5 – 15 where each sample represents a different animal, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p <0.0001.

    Journal: bioRxiv

    Article Title: Spinal Cord Microglia Exhibit Impaired Repair Responses to Myelin Damage

    doi: 10.64898/2026.02.23.707565

    Figure Lengend Snippet: (A, C). Representative immunofluorescence images of the medial corpus callosum in the brain and the dorsal region in the lumbar spinal cord stained with antibodies for MerTK and TREM2. (B, D) Mean intensities graphed to depict the comparison between brain and spinal cord. Mean intensities were obtained using Fiji Image J software. Error bars represent standard error of the mean. Statistical analysis was performed using a 3-way ANOVA with Tukey’s post-hoc analysis, n = 5 – 15 where each sample represents a different animal, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p <0.0001.

    Article Snippet: The resulting cells were incubated in an FC block solution (Tonbo 70-0161, 1:100) for 10 minutes and then stained in an antibody mix for 30 minutes which consisted of CD45 violetFluor 450 (Tonbo 75-0451, 1:75), CD11b PerCP-Cyanine5.5 (Tonbo 65-0112, 1:75), Brilliant Violet 605 anti-mouse CD16 (Biolegend 158027, 1:75), FITC anti-mouse CD68 (Biolegend 137006, 1:75), APC/Fire 810 anti-mouse CX3CR1 (Biolegend 149054, 1:75), APC anti-mouse F4/80 (Biolegend 123116, 1:75), APC/Fire 750 anti-mouse CD73 (Biolegend 127221, 1:75), PE anti-mouse TREM2 (R&D Systems FAB17291P, 1:75), and viability dye (Tonbo 13-0871, 1:1000).

    Techniques: Immunofluorescence, Staining, Comparison, Software